Once immobilized on the cell surface, ACP selectively binds to the Fc region of therapeutic IgG antibodies or antibody–drug conjugates (ADCs), equipping NK cells with antibody-directed tumor-targeting ability. The gene discussed is NDUFAB1; the disease is neoplasm.